Exelixis (EXEL) Long-Term Deferred Tax (2018 - 2026)

Exelixis' (EXEL) quarterly Long-Term Deferred Tax came in at $293.7 million in Q2 2026, down 29.9% year-on-year from $419.0 million in Q2 2025, and little changed quarter-over-quarter from $292.6 million in Q1 2026.

Exelixis (EXEL) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends

Exelixis' Long-Term Deferred Tax history runs 9 years deep, the most recent figure standing at $293.7 million for Q2 2026.

  • On a quarterly basis, Long-Term Deferred Tax fell 29.9% year-over-year to $293.7 million in Q2 2026; TTM through Apr 2026 was $293.7 million, a 29.9% decrease from a year earlier, with the FY2026 full-year figure at $292.6 million, down 30.34% from the prior year.
  • Long-Term Deferred Tax was little changed at $293.7 million in Q2 2026 per EXEL's latest filing, from $292.6 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $420.0 million in Q1 2025 and bottomed at $98.0 million in Q2 2022.
  • The 5-year median for Long-Term Deferred Tax is $293.7 million (2026), against an average of $291.6 million.
  • Across the five-year window, Long-Term Deferred Tax sank 38.98% in 2022 and jumped 134.29% in 2023, its largest moves.
  • Year by year, Long-Term Deferred Tax stood at $231.1 million in 2022, then soared by 56.27% to $361.1 million in 2023, then declined by 0.63% to $358.9 million in 2024, then gained by 16.64% to $418.6 million in 2025, then dropped by 29.83% to $293.7 million in 2026.
  • Per Business Quant, the three latest EXEL Long-Term Deferred Tax figures stand at $293.7 million (Q2 2026), $292.6 million (Q1 2026), and $418.6 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 293.73 Mn
Jan 2, 2026 292.58 Mn
Oct 3, 2025 418.58 Mn
Jul 4, 2025 419.24 Mn
Apr 4, 2025 419.05 Mn
Jan 3, 2025 420.03 Mn
Sep 27, 2024 358.87 Mn
Jun 28, 2024 361.56 Mn
Mar 29, 2024 361.58 Mn
Dec 29, 2023 361.15 Mn
Sep 29, 2023 230.99 Mn
Jun 30, 2023 231.12 Mn
Mar 31, 2023 229.60 Mn
Dec 30, 2022 231.11 Mn
Sep 30, 2022 116.42 Mn
Jul 1, 2022 113.96 Mn
Apr 1, 2022 98.00 Mn
Dec 31, 2021 111.66 Mn
Oct 1, 2021 125.30 Mn
Jul 2, 2021 134.67 Mn